For: | Guzinska-Ustymowicz K, Kemona A. Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol 2005; 11(8): 1193-1195 [PMID: 15754403 DOI: 10.3748/wjg.v11.i8.1193] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i8/1193.htm |
Number | Citing Articles |
1 |
Francesco Blasi, Chiara Bruckmann, Dmitry Penkov, Leila Dardaei. A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer. BioEssays 2017; 39(5) doi: 10.1002/bies.201600245
|
2 |
C. EVANS, A. G. DALGLEISH, D. KUMAR. Review article: immune suppression and colorectal cancer. Alimentary Pharmacology & Therapeutics 2006; 24(8): 1163 doi: 10.1111/j.1365-2036.2006.03075.x
|
3 |
J Braun, C Hoang-Vu, H Dralle, S Hüttelmaier. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010; 29(29): 4237 doi: 10.1038/onc.2010.169
|
4 |
Friedrich Prall, Christiane Ostwald. High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations. Human Pathology 2007; 38(11): 1696 doi: 10.1016/j.humpath.2007.04.002
|
5 |
Maya Gulubova, Irena Manolova, Julian Ananiev, Alexander Julianov, Yovcho Yovchev, Katya Peeva. Role of TGF-β1, its receptor TGFβRII, and Smad proteins in the progression of colorectal cancer. International Journal of Colorectal Disease 2010; 25(5): 591 doi: 10.1007/s00384-010-0906-9
|
6 |
Rong Qiu, Jian Chen, Jun Sima, Xiangdi Shen, Dandan Liu, Jian Shen. NS398 induces apoptosis in non-small cell lung cancer cells. Journal of Cancer Research and Clinical Oncology 2012; 138(1): 119 doi: 10.1007/s00432-011-1080-3
|
7 |
Sonya Youngju Park, Jinyoung Yoo. Expression of Transforming Growth Factor β1 and Cadherins in Lung Adenocarcinoma. Journal of Lung Cancer 2012; 11(1): 38 doi: 10.6058/jlc.2012.11.1.38
|
8 |
Yvonne M. Saenger, Robert R. Jenq, Miguel-Angel Perales. General Principles of Tumor Immunotherapy. 2007; : 67 doi: 10.1007/978-1-4020-6087-8_5
|
9 |
Maya Gulubova, Julian Ananiev, Yovchev Yovchev, Aleksander Julianov, Anatoli Karashmalakov, Tatyana Vlaykova. The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients’ survival. Journal of Molecular Histology 2013; 44(6): 679 doi: 10.1007/s10735-013-9520-9
|
10 |
Ali Flores-Pérez, Laurence A. Marchat, Sergio Rodríguez-Cuevas, Verónica Bautista-Piña, Alfredo Hidalgo-Miranda, Elena Aréchaga Ocampo, Mónica Sierra Martínez, Carlos Palma-Flores, Miguel A. Fonseca-Sánchez, Horacio Astudillo-de la Vega, Erika Ruíz-García, Juan Antonio González-Barrios, Carlos Pérez-Plasencia, María L. Streber, César López-Camarillo. Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep34504
|
11 |
É. J. Ryan, B. Creavin, Y. L. Khaw, M. E. Kelly, H. M. Mohan, R. Geraghty, E. J. Ryan, R. Kennelly, A. Hanly, S. T. Martin, D. Fennelly, R. McDermott, D. Gibbons, P. R O'Connell, K. Sheahan, D. C. Winter. Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer. BJS Open 2018; 2(6): 456 doi: 10.1002/bjs5.91
|
12 |
Federica Ungaro, Silvia D’Alessio, Silvio Danese. The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies. Cancers 2020; 12(8): 2060 doi: 10.3390/cancers12082060
|
13 |
F Prall. Tumour budding in colorectal carcinoma. Histopathology 2007; 50(1): 151 doi: 10.1111/j.1365-2559.2006.02551.x
|
14 |
Inti Zlobec, Alessandro Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget 2010; 1(7): 651 doi: 10.18632/oncotarget.199
|
15 |
M Mantur, J Snarska, O Koper, J Dziecioł, A Płonski, D Lemancewicz. Serum sICAM, sVCAM and sE-selectin levels in colorectal cancer patients.. Folia Histochemica et Cytobiologica 2010; 47(4) doi: 10.2478/v10042-009-0077-0
|
16 |
Wujin Chen, Yiyi Jin, Hong Yang, Lihui Wei, Jiumao Lin. Hedyotis diffusa Willd reduces migration and invasion through inhibition of TGF-β-induced EMT in colorectal cancer cells. European Journal of Integrative Medicine 2018; 23: 57 doi: 10.1016/j.eujim.2018.09.008
|
17 |
Sean C. Glasgow, Joshua I.S. Bleier, Lawrence J. Burgart, Charles O. Finne, Ann C. Lowry. Meta-analysis of Histopathological Features of Primary Colorectal Cancers that Predict Lymph Node Metastases. Journal of Gastrointestinal Surgery 2012; 16(5): 1019 doi: 10.1007/s11605-012-1827-4
|
18 |
Hao Yu, Xing-Xiu Li, Xing Han, Bin-Xin Chen, Xing-Hua Zhang, Shan Gao, Dan-Qi Xu, Yao Wang, Zhan-Kui Gao, Lei Yu, Song-Ling Zhu, Li-Chen Yao, Gui-Rong Liu, Shu-Lin Liu, Xiao-Qin Mu. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1126808
|
19 |
Miriam E. Uhlmann, Milka Georgieva, Martin Sill, Ulrich Linnemann, Martin R. Berger. Prognostic value of tumor progression-related gene expression in colorectal cancer patients. Journal of Cancer Research and Clinical Oncology 2012; 138(10): 1631 doi: 10.1007/s00432-012-1238-7
|
20 |
David Bacman, Susanne Merkel, Roland Croner, Thomas Papadopoulos, Wolfgang Brueckl, Arno Dimmler. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-156
|
21 |
Viktor H. Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in colorectal cancer—ready for diagnostic practice?. Human Pathology 2016; 47(1): 4 doi: 10.1016/j.humpath.2015.08.007
|